PER 4.76% 10.0¢ percheron therapeutics limited

Ann: ATL1103 Higher Dose Study-ANP.AX, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    Kp with regards your last post i 100% agree with what you say

    but lets try to keep it real salary had nothing to do with this Add on study hence my comments

    Would have been nice to have seen a focus on the results instead of the same old same old

    Thats all, as you say point taken so wont harp on

    Karashelle on a side note i put a suggestion to management over twelve months ago that they should consider a reissue of the oppis @ minimum cost to all oppi holders, this was taken on board and i believe is being considered, but like everything else they chose to keep us in the dark by suggesting they are monitoring the oppis LOL

    So your guess is as good as mine i believe gassy is punting on this factor but it is a punt at this moment in time as nothing has been made official.

    Hope this helps Kara
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
-0.005(4.76%)
Mkt cap ! $90.15M
Open High Low Value Volume
11.0¢ 11.0¢ 10.0¢ $54.97K 528.8K

Buyers (Bids)

No. Vol. Price($)
9 396468 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 99708 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.